HollyFrontier Corporation (NYSE:HFC) shares fell -0.12% in last trading session and ended the day at $40.56. HFC Gross Margin is 17.60% and its has a return on assets of 6.10%. HollyFrontier Corporation (NYSE:HFC) quarterly performance is -12.70%.
HollyFrontier Corporation (NYSE: HFC) announced that planned fourth quarter maintenance on the El Dorado and Cheyenne Distillate Hydrotreating units and the Tulsa West Crude and Lubricants units was complete. During the quarter, the Tulsa refinery also experienced an unplanned shutdown of its Fluid Catalytic Cracking Unit (FCCU). Repairs have been completed and the FCCU has successfully restarted. Extreme weather conditions in New Mexico have also impacted crude rate at the Navajo Refinery due to crude availability constraints.
Nuveen Real Estate Income Fund (NYSEMKT:JRS) ended the last trading day at $10.58. Company weekly volatility is calculated as 62.64. Nuveen Real Estate Income Fund (NYSEMKT:JRS) showed a weekly performance of 8.64%.
Nuveen Investments, a leading global provider of investment services to institutions as well as individual investors, announced the Nuveen Real Estate Income Fund (NYSE MKT: JRS) has declared its regular quarterly distribution. The dividend will be payable on 31st December on the record date of 15 December.
On 29 December, USMD Holdings, Inc. (NASDAQ:USMD) shares fell -5.80% and was closed at $7.64. USMD EPS growth in last 5 year was 0.00%. USMD Holdings, Inc. (NASDAQ:USMD) year to date (YTD) performance is -30.55%.
USMD Holdings, Inc. (NASDAQ: USMD) has entered into a definitive agreement to sell most of its lithotripsy division to United Medical Systems (UMS), a leading provider of mobile medical equipment and services, including urology, women’s health and MRI imaging, to hospitals, surgery centers and physician offices across the U.S., Canada and South America. This deal was finalized on December 18, 2015.
American Midstream Partners, LP (NYSE:AMID) shares fell -5.29% in last trading session and ended the day at $6.81. AMID Gross Margin is 51.80% and its has a return on assets of -13.30%. American Midstream Partners, LP (NYSE:AMID) quarterly performance is -34.87%.
Affiliates of ArcLight Capital Partners, LLC (“ArcLight”), which controls the general partner of American Midstream Partners, LP (NYSE:AMID) (the “Partnership”) announced that ArcLight has approved a unit purchase program (the “Purchase Program”) whereby ArcLight may purchase up to $75 million of common units of the Partnership.
Cytokinetics, Incorporated (NASDAQ:CYTK) caters to the Healthcare space. It has a net profit margin of -48.90% and weekly performance is -2.70%. On the last day of trading company shares ended up at $10.47. Cytokinetics, Incorporated (NASDAQ:CYTK) distance from 50-day simple moving average (SMA50) is 0.59%.
Piper Jaffray reiterated their buy rating on shares of Cytokinetics, Inc. (NASDAQ:CYTK) in a research report report published on Wednesday morning, Market Beat Ratings reports. They currently have a $24.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $17.00.
Leave a Reply